Skip to main content

Published locations for Rituximab maintenance halves MCL death risk after ASCT

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Rituximab maintenance halves MCL death risk after ASCT

User login

  • Reset your password
  • /content/rituximab-maintenance-halves-mcl-death-risk-after-asct
  • /hematologynews/article/148156/mantle-cell-lymphoma/rituximab-maintenance-halves-mcl-death-risk-after
  • /oncologypractice/article/148156/mantle-cell-lymphoma/rituximab-maintenance-halves-mcl-death-risk
  • /hematology-oncology/article/148156/mantle-cell-lymphoma/rituximab-maintenance-halves-mcl-death-risk
  • /b-cell-lymphoma-icymi/article/148156/mantle-cell-lymphoma/rituximab-maintenance-halves-mcl-death